Literature DB >> 23625276

Breast cancer screening and the changing population pyramid of Japan.

Ken Uchida1, Hitoshi Ohashi, Satoki Kinoshita, Hiroko Nogi, Kumiko Kato, Yasuo Toriumi, Akinori Yamashita, Makiko Kamio, Rei Mimoto, Hiroshi Takeyama.   

Abstract

BACKGROUND: Breast cancer has been the most prevalent cancer in Japan since the 1990s. The mortality from breast cancer is increasing in Japan, whereas in other industrialized countries it has been decreasing since 1990. On the other hand, Japan faces unparalleled growth in its aging population. The aim of this study was to report the mammography screening among Japanese women and the related upcoming changes in the population pyramid of Japan. DATA SOURCES AND METHODS: The reference data for our study were obtained from the Center for Cancer Control and Information Services, Japan Ministry of Internal Affairs and Communications, Ministry of Health, Labour and Welfare, the Japanese Cancer Society, and the National Institute of Population and Social Security. The survey data were obtained from breast cancer and mammography screenings in the Tokyo Prefecture in 2008. The following parameters were analyzed: annual breast cancer incidence, current screening rates, average life-span, and predicted demographic statistics.
RESULTS: Our results showed that breast cancer incidence and mortality have been increasing annually in Japan. The average age of breast cancer patients increased to 58.40 years in 2010. The incidence of breast cancer in women aged 65 years and older increased from 25.3 to 32.9 % in the last 10 years and is expected to continue to increase in the future. The check-up rate was 16.0-20.0 % for women aged 65-74 years and 43.0-46.0 % for women aged 40-54 years. According to our questionnaire survey, concerns about breast cancer and mammography screening were high in the young and low in the elderly women. The Japanese population aged 65 years and older was 30,740 (24.1 %) in 2012 and is estimated to increase by 40 % over the next 20 years despite Japan's declining population size.
CONCLUSION: Breast cancer incidence has increased in Japan, even among patients aged 65 years and older. Breast cancer has become increasingly prevalent in older Japanese women. As the population pyramid of Japan changes, women aged 65 years and older, who think that there is no longer need to receive mammography screening and are not educated regarding self-examinations, should be encouraged to receive regular check-ups for breast cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23625276     DOI: 10.1007/s12282-013-0470-6

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  13 in total

1.  Investigation of the significance of population-based breast cancer screening among women aged under 40 years.

Authors:  Mai Okazaki; Hiroko Bando; Eriko Tohno; Yuka Kujiraoka; Akiko Iguchi-Manaka; Emika Ichioka; Yukiko Tsushima; Hiroshi Watanabe; Hisato Hara
Journal:  Breast Cancer       Date:  2020-07-08       Impact factor: 4.239

2.  Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study.

Authors:  Rin Ogiya; Naoki Niikura; Hiraku Kumamaru; Yoshinori Takeuchi; Takuho Okamura; Takayuki Kinoshita; Kenjiro Aogi; Keisei Anan; Kotaro Iijima; Takanori Ishida; Takayuki Iwamoto; Masaaki Kawai; Yasuyuki Kojima; Takashi Sakatani; Yasuaki Sagara; Naoki Hayashi; Hideji Masuoka; Masayuki Yoshida; Hiroaki Miyata; Hitoshi Tsuda; Shigeru Imoto; Hiromitsu Jinno
Journal:  Breast Cancer Res Treat       Date:  2020-08-20       Impact factor: 4.872

3.  Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women.

Authors:  Rena Yamazaki; Masafumi Inokuchi; Satoko Ishikawa; Subaru Myojo; Junpei Iwadare; Yukiko Bono; Yasunari Mizumoto; Mitsuhiro Nakamura; Masahiro Takakura; Takashi Iizuka; Tetsuo Ohta; Hiroshi Fujiwara
Journal:  Springerplus       Date:  2015-08-19

4.  Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.

Authors:  Koji Takada; Shinichiro Kashiwagi; Yuka Asano; Wataru Goto; Tamami Morisaki; Katsuyuki Takahashi; Hisakazu Fujita; Tsutomu Takashima; Shuhei Tomita; Kosei Hirakawa; Masaichi Ohira
Journal:  BMC Cancer       Date:  2020-06-03       Impact factor: 4.430

5.  Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis.

Authors:  Wataru Ando; Kiyoshi Kikuchi; Takayuki Uematsu; Hiroaki Yokomori; Takashi Takaki; Masaya Sogabe; Yutaka Kohgo; Katsuya Otori; Shigemi Ishikawa; Isao Okazaki
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

6.  The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.

Authors:  Wakako Tajiri; Hideki Ijichi; Katsumi Takizawa; Yumiko Koi; Takanobu Masuda; Hiroki Ueo; Chinami Koga; Yoshiaki Nakamura; Kenichi Taguchi; Masahiro Okamoto; Eriko Tokunaga
Journal:  Breast Cancer       Date:  2020-06-29       Impact factor: 4.239

7.  At what age should screening mammography be recommended for Asian women?

Authors:  Junko Tsuchida; Masayuki Nagahashi; Omar M Rashid; Kazuaki Takabe; Toshifumi Wakai
Journal:  Cancer Med       Date:  2015-04-27       Impact factor: 4.452

8.  Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer.

Authors:  Mariko Kikuchi; Keishi Yamashita; Mina Waraya; Naoko Minatani; Hideki Ushiku; Ken Kojo; Akira Ema; Yoshimasa Kosaka; Hiroshi Katoh; Norihiko Sengoku; Takumo Enomoto; Hirokazu Tanino; Masakazu Sawanobori; Masahiko Watanabe
Journal:  Oncotarget       Date:  2016-01-12

9.  Psychometric properties of the Breast Cancer Awareness Measurement among Chinese women: a cross-sectional study.

Authors:  Na Liu; Ping Li; Jie Wang; Dan-Dan Chen; Wei-Jia Sun; Ping-Ping Guo; Xue-Hui Zhang; Wei Zhang
Journal:  BMJ Open       Date:  2020-03-09       Impact factor: 2.692

10.  Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2018.

Authors:  Seri Hong; Yun Yeong Lee; Jaeho Lee; Yeol Kim; Kui Son Choi; Jae Kwan Jun; Mina Suh
Journal:  Cancer Res Treat       Date:  2020-10-20       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.